Signal active
Organization
Contact Information
Overview
Zavante is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.
About
Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics
2015
11-50
Headquarters locations
San Diego, California, United States, North America
Social
Profile Resume
Zavante Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $5.2B in funding across 80 round(s). With a team of 11-50 employees, Zavante Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Zavante Therapeutics, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
1
0
$65.0M
Details
1
Zavante Therapeutics has raised a total of $65.0M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2016 | Early Stage Venture | 45.0M |
Investors
Zavante Therapeutics is funded by 13 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Zavante Therapeutics | - | FUNDING ROUND - Zavante Therapeutics | 45.0M |
Global Source Ventures | - | FUNDING ROUND - Global Source Ventures | 45.0M |
Zavante Therapeutics | - | FUNDING ROUND - Zavante Therapeutics | 10.0M |
Square 1 Bank | - | FUNDING ROUND - Square 1 Bank | 10.0M |
Recent Activity
Funding Round
Jan 01, 2021
Zavante Therapeutics raised an undisclosed amount on 2021-01-01 in Venture Round
Funding Round
Sep 01, 2016
Zavante Therapeutics raised $10000000 on 2016-09-01 in Debt Financing
Funding Round
Mar 30, 2016
Zavante Therapeutics raised $45000000 on 2016-03-30 in Series A
Funding Round
Dec 23, 2015
Zavante Therapeutics raised $10000000 on 2015-12-23 in Venture Round